vs
Encompass Health Corp（EHC）与Masco（MAS）财务数据对比。点击上方公司名可切换其他公司
Masco的季度营收约是Encompass Health Corp的1.2倍（$1.9B vs $1.5B），Masco净利率更高（11.9% vs 9.5%，领先2.4%），Encompass Health Corp同比增速更快（9.9% vs 6.5%），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs -4.2%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
美国家居建材企业Masco主营家装及新建住宅市场相关产品，旗下拥有20余家子公司，在全球运营近80座生产工厂，其中美国本土近60座，海外地区超20座。公司1969年于纽交所挂牌上市，后实现快速增长，成功跻身美国财富500强榜单。
EHC vs MAS — 直观对比
营收规模更大
MAS
是对方的1.2倍
$1.5B
营收增速更快
EHC
高出3.4%
6.5%
净利率更高
MAS
高出2.4%
9.5%
两年增速更快
EHC
近两年复合增速
-4.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.9B |
| 净利润 | $146.1M | $228.0M |
| 毛利率 | — | 35.8% |
| 营业利润率 | 16.7% | 16.5% |
| 净利率 | 9.5% | 11.9% |
| 营收同比 | 9.9% | 6.5% |
| 净利润同比 | 20.8% | 14.5% |
| 每股收益（稀释后） | $1.43 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCMAS
| Q1 26 | — | $1.9B | ||
| Q4 25 | $1.5B | $1.8B | ||
| Q3 25 | $1.5B | $1.9B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $1.8B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.4B | $2.0B | ||
| Q2 24 | $1.3B | $2.1B |
净利润EHCMAS
| Q1 26 | — | $228.0M | ||
| Q4 25 | $146.1M | $165.0M | ||
| Q3 25 | $126.5M | $189.0M | ||
| Q2 25 | $142.1M | $270.0M | ||
| Q1 25 | $151.5M | $186.0M | ||
| Q4 24 | $120.9M | $182.0M | ||
| Q3 24 | $108.2M | $167.0M | ||
| Q2 24 | $114.1M | $258.0M |
毛利率EHCMAS
| Q1 26 | — | 35.8% | ||
| Q4 25 | — | 33.9% | ||
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | 37.6% | ||
| Q1 25 | — | 35.8% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 37.5% |
营业利润率EHCMAS
| Q1 26 | — | 16.5% | ||
| Q4 25 | 16.7% | 13.8% | ||
| Q3 25 | 14.9% | 15.8% | ||
| Q2 25 | 16.2% | 20.1% | ||
| Q1 25 | 16.4% | 15.9% | ||
| Q4 24 | 14.3% | 15.9% | ||
| Q3 24 | 13.6% | 18.0% | ||
| Q2 24 | 14.3% | 19.0% |
净利率EHCMAS
| Q1 26 | — | 11.9% | ||
| Q4 25 | 9.5% | 9.2% | ||
| Q3 25 | 8.6% | 9.9% | ||
| Q2 25 | 9.7% | 13.2% | ||
| Q1 25 | 10.4% | 10.3% | ||
| Q4 24 | 8.6% | 10.0% | ||
| Q3 24 | 8.0% | 8.4% | ||
| Q2 24 | 8.8% | 12.3% |
每股收益（稀释后）EHCMAS
| Q1 26 | — | — | ||
| Q4 25 | $1.43 | $0.81 | ||
| Q3 25 | $1.24 | $0.90 | ||
| Q2 25 | $1.39 | $1.28 | ||
| Q1 25 | $1.48 | $0.87 | ||
| Q4 24 | $1.18 | $0.85 | ||
| Q3 24 | $1.06 | $0.77 | ||
| Q2 24 | $1.12 | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | — |
| 总债务越低越好 | $2.4B | $2.9B |
| 股东权益账面价值 | $2.4B | $27.0M |
| 总资产 | $7.1B | $5.2B |
| 负债/权益比越低杠杆越低 | 1.00× | 109.07× |
8季度趋势，按日历期对齐
现金及短期投资EHCMAS
| Q1 26 | — | — | ||
| Q4 25 | $72.2M | $647.0M | ||
| Q3 25 | $48.7M | $559.0M | ||
| Q2 25 | $99.1M | $390.0M | ||
| Q1 25 | $95.8M | $377.0M | ||
| Q4 24 | $85.4M | $634.0M | ||
| Q3 24 | $147.8M | $646.0M | ||
| Q2 24 | $154.4M | $398.0M |
总债务EHCMAS
| Q1 26 | — | $2.9B | ||
| Q4 25 | $2.4B | $2.9B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | $2.9B | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — |
股东权益EHCMAS
| Q1 26 | — | $27.0M | ||
| Q4 25 | $2.4B | $-185.0M | ||
| Q3 25 | $2.4B | $-78.0M | ||
| Q2 25 | $2.3B | $-84.0M | ||
| Q1 25 | $2.2B | $-254.0M | ||
| Q4 24 | $2.1B | $-279.0M | ||
| Q3 24 | $2.0B | $-88.0M | ||
| Q2 24 | $1.8B | $-26.0M |
总资产EHCMAS
| Q1 26 | — | $5.2B | ||
| Q4 25 | $7.1B | $5.2B | ||
| Q3 25 | $6.9B | $5.3B | ||
| Q2 25 | $6.8B | $5.3B | ||
| Q1 25 | $6.6B | $5.1B | ||
| Q4 24 | $6.5B | $5.0B | ||
| Q3 24 | $6.5B | $5.3B | ||
| Q2 24 | $6.4B | $5.4B |
负债/权益比EHCMAS
| Q1 26 | — | 109.07× | ||
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | — |
| 自由现金流经营现金流 - 资本支出 | $116.7M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 14.8% | 1.8% |
| 现金转化率经营现金流/净利润 | 2.37× | — |
| 过去12个月自由现金流最近4个季度 | $439.2M | — |
8季度趋势，按日历期对齐
经营现金流EHCMAS
| Q1 26 | — | — | ||
| Q4 25 | $346.0M | $418.0M | ||
| Q3 25 | $270.8M | $456.0M | ||
| Q2 25 | $270.2M | $306.0M | ||
| Q1 25 | $288.6M | $-158.0M | ||
| Q4 24 | $278.8M | $407.0M | ||
| Q3 24 | $267.8M | $416.0M | ||
| Q2 24 | $217.4M | $346.0M |
自由现金流EHCMAS
| Q1 26 | — | — | ||
| Q4 25 | $116.7M | $371.0M | ||
| Q3 25 | $83.7M | $415.0M | ||
| Q2 25 | $113.3M | $270.0M | ||
| Q1 25 | $125.5M | $-190.0M | ||
| Q4 24 | $80.1M | $351.0M | ||
| Q3 24 | $120.3M | $378.0M | ||
| Q2 24 | $60.5M | $303.0M |
自由现金流率EHCMAS
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 20.7% | ||
| Q3 25 | 5.7% | 21.6% | ||
| Q2 25 | 7.8% | 13.2% | ||
| Q1 25 | 8.6% | -10.5% | ||
| Q4 24 | 5.7% | 19.2% | ||
| Q3 24 | 8.9% | 19.1% | ||
| Q2 24 | 4.6% | 14.5% |
资本支出强度EHCMAS
| Q1 26 | — | 1.8% | ||
| Q4 25 | 14.8% | 2.6% | ||
| Q3 25 | 12.7% | 2.1% | ||
| Q2 25 | 10.8% | 1.8% | ||
| Q1 25 | 11.2% | 1.8% | ||
| Q4 24 | 14.1% | 3.1% | ||
| Q3 24 | 10.9% | 1.9% | ||
| Q2 24 | 12.1% | 2.1% |
现金转化率EHCMAS
| Q1 26 | — | — | ||
| Q4 25 | 2.37× | 2.53× | ||
| Q3 25 | 2.14× | 2.41× | ||
| Q2 25 | 1.90× | 1.13× | ||
| Q1 25 | 1.90× | -0.85× | ||
| Q4 24 | 2.31× | 2.24× | ||
| Q3 24 | 2.48× | 2.49× | ||
| Q2 24 | 1.91× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
MAS
暂无分部数据
